Quality CDMO
Private Company
Funding information not available
Overview
Quality CDMO is a privately held, US-based CDMO founded in 2018, providing end-to-end services from formulation development to commercial manufacturing and serialization for OTC pharmaceuticals, supplements, and skincare. The company leverages its 44,000 sq. ft. cGMP facility and expertise in liquid and semi-solid dosage forms to serve clients needing reliable, compliant manufacturing partners. Its value proposition centers on quality, agility, and collaborative partnerships, supported by positive client testimonials highlighting its cost-effectiveness and responsiveness. As a service provider, it is in a revenue-generating stage, capitalizing on the growing outsourcing trend in the consumer health and OTC sectors.
Technology Platform
Integrated CDMO infrastructure specializing in formulation, cGMP manufacturing, and serialization for non-sterile liquid and semi-solid dosage forms (creams, lotions, ointments, suspensions, suppositories).
Opportunities
Risk Factors
Competitive Landscape
Operates in a crowded CDMO sector, competing with large global players (e.g., Catalent, Lonza) and numerous smaller, specialized U.S. CDMOs. Its differentiation lies in its specific focus on OTC liquid/semi-solid formulations and DSCSA serialization within a U.S. facility, appealing to clients seeking expertise in this niche and domestic supply chain security.